NSUN2 and breast carcinoma: Given that alterations involving increased expression of NSUN2 are common in breast cancer [93,95,98], colon cancer [92,93], and lung cancer as suggested in the suggestions above, molecularly targeting this RNMT would appear to an attractive approach moving forward.